Mechanisms accounting for the impaired natural-killer cell activity in refractory anaemia with excess of blasts
- 24 April 2009
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 48 (5) , 237-243
- https://doi.org/10.1111/j.1600-0609.1992.tb01800.x
Abstract
Natural killer (NK) cells were analyzed in 38 untreated patients with refractory anaemia with excess of blasts (RAEB), using cytotoxicity assays and immunofluorescence with monoclonal antibodies. We found that patients with RAEB have normal numbers of peripheral blood and bone marrow NK cells. NK cells from RAEB patients express very low natural-killer cell activity (NKa) which may be increased significantly with recombinant alpha-interferon and recombinant interleukin-2, although it remains below the lower limit of the control range. The cells exhibit normal tumour cell binding capacity, but fail to release sufficient amounts of natural-killer cytotoxic factors (NKCFs) upon their interaction with NK-sensitive K562 cell targets or their stimulation with phytohaemagglutinin. Our results suggest that defective NKa in RAEB patients may be due, at least in part, to impaired release of functionally active NKCFs. This disturbance is probably the result of some intrinsic defect of RAEB NK cells in NKCF production, storage, and/or release. The possibility of an impairment in the activation signal provided by the stimulatory K562 cells cannot be excluded, although it seems unlikely. We postulate that this abnormality might represent a manifestation of dysplastic haemopoiesis. Further studies are certainly needed to investigate whether other defective mechanisms are also implicated in the determination of the low NKa in patients with RAEB.Keywords
This publication has 19 references indexed in Scilit:
- Decreased natural killer cell activity versus normal natural killer cell markers in mononuclear cells from patients with smouldering leukemiaScandinavian Journal of Haematology, 2009
- Interleukin-1α and tumor necrosis factor-α protect cells against natural killer cell-mediated cytotoxicity and natural killer cytotoxic factorCellular Immunology, 1990
- Impaired α‐interferon production and natural killer activity in blood mononuclear cells in myelodysplastic syndromesScandinavian Journal of Haematology, 1986
- Immunoregulatory abnormalities in myelodysplastic disordersAmerican Journal of Hematology, 1986
- Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications.Journal of Clinical Pathology, 1985
- Immune abnormalities in myelodysplastic syndromes.Journal of Clinical Pathology, 1985
- Natural killer‐interferon system in patients with preleukaemic statesBritish Journal of Haematology, 1984
- Decreased T helper cells in the myelodysplastic syndromesBritish Journal of Haematology, 1983
- RECOGNITION OF MARROW ELEMENTS BY NATURAL KILLER CELLS: ARE NK CELLS INVOLVED IN HAEMOPOIETC REGULATION?British Journal of Haematology, 1983
- Natural Killer Cells: Their Roles in Defenses Against DiseaseScience, 1981